Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 9,192,876 11,754,664
Convertible notes    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 21,136
Warrants    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 5,636,801 5,996,112
Options    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 934,729 1,071,782
Restricted stock units    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 2,621,346 4,665,060
Restricted shares    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 574